CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
Home
Official URL : http://fhir.ch/ig/ch-epl/ImplementationGuide/ch.fhir.ig.ch-epl
Version :
1.0.1
Active
as of 2026-03-06
Computable Name : CH_EPL
Copyright/Legal : CC0-1.0
Introduction
The CH ePL is a major digital transformation project initiated by the Federal Office of Public Health (FOPH) in Switzerland to modernise how key healthcare benefit lists (including the specialities list and MiGeL) and their processes are managed, published, and exchanged electronically.
FHIR ressources for IDMP
This implementation guide uses the following FHIR resource to represent the context of the international ISO IDMP (Identification of Medicinal Products) standard:
This implementation guide is dependent on
which describe the international context, especially related to IDMP.
Documentation
This implementation guide describes the exchange formats, structures, datafields and handlings of the "Specialities List".
The following documents have been defined (and described in more detail on the respective subsections):
FOPH ePL : Description and summary of the scope ePL project of FOPH (Federal Office of Public Health)
HL7 FHIR Standard : Short description and explanation of the FHIR standard.
ISO IDMP Standard (ISO 11615) : Introduction into the IDMP standard of ISO.
IDMP and FHIR : Explanation on how IDMP is build in FHIR.
The IDMP implentations
Swiss IDMP Implementation : Overview of the IDMP implementation in Switzerland
EMA IDMP Implementation : Introduction of the IDMP implemantation by the European Medicines Agency for the European Union.
Swissmedic IDMP Implementation : Introduction of the IDMP implementation by Swissmedic for Switzerland
FOPH Speciality List : Introduction on the IDMP implemantation and its FHIR extensions developed for FOPH.
Changelog with significant changes, open and closed issues.
Download : You can download this implementation guide in the npm format from here .
Collaboration
This guide is the product of collaborative work undertaken with participants from:
IP Statements
This document is licensed under Creative Commons "No Rights Reserved" (CC0 ).
HL7®, HEALTH LEVEL SEVEN®, FHIR® and the FHIR ® are trademarks owned by Health Level Seven International, registered with the United States Patent and Trademark Office.
This publication includes IP covered under the following statements.
CC0-1.0 Show Usage
CH SMC - Additional Monitoring Indicator : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPMedicinalProductDefinition , ChSMCAdditionalMonitoringIndicatorVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH SMC - Attached Document Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 19 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChSMCAttachedDocumentTypeVS , DocumentReference/DocRef-FI-Abrilada , DocumentReference/DocRef-FI-Cuprior , DocumentReference/DocRef-FI-Entocort , DocumentReference/DocRef-FI-Estalis , DocumentReference/DocRef-FI-Keytruda , DocumentReference/DocRef-FI-Paxlovid , DocumentReference/DocRef-FI-Triogen , DocumentReference/DocRef-PI-Abrilada , DocumentReference/DocRef-PI-Cuprior , DocumentReference/DocRef-PI-Entocort , DocumentReference/DocRef-PI-Estalis , DocumentReference/DocRef-PI-Paxlovid and DocumentReference/DocRef-PI-Triogen
CH SMC - Authorisation Category : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 13 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChSMCAuthorisationCategoryVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH SMC - Authorisation Status : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 22 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPRegulatedAuthorization , ChSMCAuthorisationStatusVS , RegulatedAuthorization/MA-5204201 , RegulatedAuthorization/MA-52042011 , RegulatedAuthorization/MA-5470402 , RegulatedAuthorization/MA-54704089 , RegulatedAuthorization/MA-66231001 , RegulatedAuthorization/MA-6623101 , RegulatedAuthorization/MA-67431001 , RegulatedAuthorization/MA-6743101 , RegulatedAuthorization/MA-67719001 , RegulatedAuthorization/MA-6771901 , RegulatedAuthorization/MA-67831001 , RegulatedAuthorization/MA-67831002 , RegulatedAuthorization/MA-6783101 , RegulatedAuthorization/MA-68793001 and RegulatedAuthorization/MA-6879301
CH SMC - Ingredient Role : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 7 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPIngredient and ChSMCIngredientRoleVS
CH SMC - Legal Status of Supply : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 21 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChSMCLegalStatusOfSupplyVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet , MedicinalProductDefinition/Triogen-250mg-Capsule , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-1-Pre-Filled-Pen , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-2-Pre-Filled-Pen , PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet , PackagedProductDefinition/PMP-Entocort-Solvent-and-Tablet , PackagedProductDefinition/PMP-Estalis-Transdermalpatch , PackagedProductDefinition/PMP-Keytruda-100mg-4ml-Solution-for-Infusion , PackagedProductDefinition/PMP-Paxlovid-Filmcoatedtablet and PackagedProductDefinition/PMP-Triogen-250mg-Capsule
CH SMC - Marketing Status : CHIDMPPackagedProductDefinition and ChSMCMarketingStatusVS
CH SMC - Pediatric Use Indicator : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPMedicinalProductDefinition , ChSMCPediatricUseIndicatorVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH SMC - Special Precautions for Storage : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChSMCSpecialPrecautionsForStorageVS , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-1-Pre-Filled-Pen , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-2-Pre-Filled-Pen , PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet , PackagedProductDefinition/PMP-Entocort-Solvent-and-Tablet , PackagedProductDefinition/PMP-Estalis-Transdermalpatch , PackagedProductDefinition/PMP-Keytruda-100mg-4ml-Solution-for-Infusion , PackagedProductDefinition/PMP-Paxlovid-Filmcoatedtablet and PackagedProductDefinition/PMP-Triogen-250mg-Capsule
CH SMC - Substance : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 7 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPIngredient and ChSMCSubstanceVS
CH SMC - TherapeuticProductcode : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 13 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChSMCTherapeuticProductcodeVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH - Authorisation Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 30 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPRegulatedAuthorization , ChAuthorisationTypeVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21203-2-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 , RegulatedAuthorization/FOPH-21529 , RegulatedAuthorization/MA-5204201 , RegulatedAuthorization/MA-52042011 , RegulatedAuthorization/MA-5470402 , RegulatedAuthorization/MA-54704089 , RegulatedAuthorization/MA-66231001 , RegulatedAuthorization/MA-6623101 , RegulatedAuthorization/MA-67431001 , RegulatedAuthorization/MA-6743101 , RegulatedAuthorization/MA-67719001 , RegulatedAuthorization/MA-6771901 , RegulatedAuthorization/MA-67831001 , RegulatedAuthorization/MA-67831002 , RegulatedAuthorization/MA-6783101 , RegulatedAuthorization/MA-68793001 and RegulatedAuthorization/MA-6879301
CH EPL - Gamme : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 13 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplGammeVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 and RegulatedAuthorization/FOPH-21529
CH EPL - Index Therapeuticus : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 13 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ITCVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH EPL - Limitation Status : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplLimitationStatusVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21203-2-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 and RegulatedAuthorization/FOPH-21529
CH EPL - Listing Status : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplListingStatusVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21203-2-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 and RegulatedAuthorization/FOPH-21529
CH EPL - Other Characteristics Packaged Item : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , ChEplOtherCharacteristicsPackagedItemVS and PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet
CH EPL - Price Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplPricetypeVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21203-2-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 and RegulatedAuthorization/FOPH-21529
CH EPL - Product Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 13 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplProductTypeVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH EPL - Reimbursement Status : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplReimbursementStatusVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21203-2-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 and RegulatedAuthorization/FOPH-21529
CH EPL - Type of Price Change : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChEplTypeofPriceChangeVS , RegulatedAuthorization/FOPH-17418 , RegulatedAuthorization/FOPH-17973 , RegulatedAuthorization/FOPH-20416 , RegulatedAuthorization/FOPH-21070 , RegulatedAuthorization/FOPH-21203-1-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21203-2-Pre-Filled-Pen , RegulatedAuthorization/FOPH-21208 and RegulatedAuthorization/FOPH-21529
CH - Medicinal Product Name Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 13 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChMedicinalProductNameTypeVS , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
CH - Other Characteristics Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , ChOtherCharacteristicsTypeVS and PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet
EMA - Domain : EMADomainVS
EMA - Shelf Life Type : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 14 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , EMAShelfLifeTypeVS , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-1-Pre-Filled-Pen , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-2-Pre-Filled-Pen , PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet , PackagedProductDefinition/PMP-Entocort-Solvent-and-Tablet , PackagedProductDefinition/PMP-Estalis-Transdermalpatch , PackagedProductDefinition/PMP-Keytruda-100mg-4ml-Solution-for-Infusion , PackagedProductDefinition/PMP-Paxlovid-Filmcoatedtablet and PackagedProductDefinition/PMP-Triogen-250mg-Capsule
EMA - Intended Effect : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 39 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPClinicalUseDefinitionIndication , ClinicalUseDefinition/IND-10002556 , ClinicalUseDefinition/IND-10003268 , ClinicalUseDefinition/IND-10009900 , ClinicalUseDefinition/IND-10019927 , ClinicalUseDefinition/IND-10020041 , ClinicalUseDefinition/IND-10021782 , ClinicalUseDefinition/IND-10027400 , ClinicalUseDefinition/IND-10028881 , ClinicalUseDefinition/IND-10030247 , ClinicalUseDefinition/IND-10031285 , ClinicalUseDefinition/IND-10037153 , ClinicalUseDefinition/IND-10037160 , ClinicalUseDefinition/IND-10043971 , ClinicalUseDefinition/IND-10045365 , ClinicalUseDefinition/IND-10046851 , ClinicalUseDefinition/IND-10061091 , ClinicalUseDefinition/IND-10075566 , ClinicalUseDefinition/IND-10084529 , ClinicalUseDefinition/IND-10089182 , ClinicalUseDefinition/LIM-156370009 , ClinicalUseDefinition/LIM-20416.XX , ClinicalUseDefinition/LIM-254837009 , ClinicalUseDefinition/LIM-34000006 , ClinicalUseDefinition/LIM-59393003 , ClinicalUseDefinition/LIM-64766004-ABRILADA , ClinicalUseDefinition/LIM-64766004-ENTOCORT , ClinicalUseDefinition/LIM-69896004 , ClinicalUseDefinition/LIM-79886009-CUPRIOR , ClinicalUseDefinition/LIM-79886009-TRIOGEN , ClinicalUseDefinition/LIM-840539006 , ClinicalUseDefinition/LIM-9014002 , ClinicalUseDefinition/LIM-9631008 and EMAIntendedEffectVS
EDQM - Standard Terms : AdministrableProductDefinition/PhP-Abrilada-40mg-Pre-Filled-Pen , AdministrableProductDefinition/PhP-Budesonidum-Suspension ... Show 47 more , AdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch , AdministrableProductDefinition/PhP-Nirmatrelvir-150mg-Filmcoatedtablet , AdministrableProductDefinition/PhP-Pembrolizumab-100mg-Vial , AdministrableProductDefinition/PhP-Ritonavirum-100mg-Filmcoatedtablet , AdministrableProductDefinition/PhP-Trientinum-150mg-Filmcoatedtablet , AdministrableProductDefinition/PhP-Trientinum-250mg-Capsule , Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , CHIDMPManufacturedItemDefinition , CHIDMPMedicinalProductDefinition , CHIDMPPackagedProductDefinition , EdqmCombinationPackagingVS , EdqmCombinedPharmaceuticalDoseFormVS , EdqmCombinedTermVS , EdqmPackagingVS , EdqmPharmaceuticalDoseFormVS , EdqmRouteOfAdministrationVS , EdqmUnitOfPresentationVS , ManufacturedItemDefinition/MI-Abrilada-40mg-Pre-Filled-Pen , ManufacturedItemDefinition/MI-Budesonidum-2.3mg-Tablet , ManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch , ManufacturedItemDefinition/MI-Nirmatrelvir-150mg , ManufacturedItemDefinition/MI-Pembrolizumab-100mg-Vial , ManufacturedItemDefinition/MI-Ritonavirum-100mg , ManufacturedItemDefinition/MI-Solvent , ManufacturedItemDefinition/MI-Trientinum-150mg-Filmcoatedtablet , ManufacturedItemDefinition/MI-Trientinum-250mg-Capsule , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet , MedicinalProductDefinition/Triogen-250mg-Capsule , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-1-Pre-Filled-Pen , PackagedProductDefinition/PMP-Abrilada-40mg-0.8ml-2-Pre-Filled-Pen , PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet , PackagedProductDefinition/PMP-Entocort-Solvent-and-Tablet , PackagedProductDefinition/PMP-Estalis-Transdermalpatch , PackagedProductDefinition/PMP-Keytruda-100mg-4ml-Solution-for-Infusion , PackagedProductDefinition/PMP-Paxlovid-Filmcoatedtablet and PackagedProductDefinition/PMP-Triogen-250mg-Capsule
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org . Show Usage
SNOMED Clinical Terms® (SNOMED CT®): Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 35 more , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , ChAuthorisationTypeCS , ChEplGammeCS , ChEplLimitationStatusCS , ChEplListingStatusCS , ChEplOtherCharacteristicsPackagedItemCS , ChEplPriceTypeCS , ChEplProductTypeCS , ChEplReimbursementStatusCS , ChEplTypeOfPriceChangeCS , ChSMCAdditionalMonitoringIndicatorCS , ChSMCAttachedDocumentTypeCS , ChSMCAuthorisationCategoryCS , ChSMCAuthorisationStatusCS , ChSMCIngredientRoleCS , ChSMCLegalStatusOfSupplyCS , ChSMCPediatricUseIndicatorCS , ChSMCSpecialPrecautionsForStorageCS , ChSMCTherapeuticProductcodeCS , ClinicalUseDefinition/LIM-156370009 , ClinicalUseDefinition/LIM-254837009 , ClinicalUseDefinition/LIM-34000006 , ClinicalUseDefinition/LIM-59393003 , ClinicalUseDefinition/LIM-64766004-ABRILADA , ClinicalUseDefinition/LIM-64766004-ENTOCORT , ClinicalUseDefinition/LIM-69896004 , ClinicalUseDefinition/LIM-79886009-CUPRIOR , ClinicalUseDefinition/LIM-79886009-TRIOGEN , ClinicalUseDefinition/LIM-840539006 , ClinicalUseDefinition/LIM-9014002 , ClinicalUseDefinition/LIM-9631008 and ITC
WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed. Show Usage
ATC classification system : Bundle/08f553cb-1404-4972-bf14-2023a5f59955 , Bundle/3e18bbe5-4cc2-4eaa-8d27-815c0e885025 ... Show 12 more , Bundle/5bb930aa-f30d-4f10-aeef-e85f6b5f8d59 , Bundle/6722a9ee-ae3b-4c20-bcf0-9b7cb6f062db , Bundle/a69ea53d-79d4-46f4-bd2e-7a71439f148f , Bundle/b2eb19be-cca4-4fd8-a2a3-84d05631e6c0 , Bundle/c97d5d89-4467-4c1e-9954-9d1e1d1d46e2 , MedicinalProductDefinition/Abrilada-40mg-Pre-Filled-Pen , MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet , MedicinalProductDefinition/Entocort-Solvent-and-Tablet , MedicinalProductDefinition/Estalis-Transdermalpatch , MedicinalProductDefinition/Keytruda-100mg-Vial , MedicinalProductDefinition/Paxlovid-Filmcoatedtablet and MedicinalProductDefinition/Triogen-250mg-Capsule
Cross Version Analysis
This IG can only be used with FHIR R5 systems.
Dependency Table
Package hl7.fhir.uv.extensions.r5#5.2.0
This IG defines the global extensions - the ones defined for everyone. These extensions are always in scope wherever FHIR is being used (built Mon, Feb 10, 2025 21:45+1100+11:00)
Package hl7.fhir.uv.tools.r5#1.1.2
This IG defines the extensions that the tools use internally. Some of these extensions are content that are being evaluated for elevation into the main spec, and others are tooling concerns (built Tue, Mar 24, 2026 11:13+1100+11:00)
CH-ePL currently has no dependency on ch-core, as ch-core is based on FHIR R4, whereas CH-ePL is based on R5. The use of R5 was necessary because IDMP support is only available from R5 onwards.
Looking ahead (expected around 2028), the dependencies of CH-ePL are likely to be updated. By that time, a Swiss IDMP base FHIR Implementation Guide is expected to be published, and CH-ePL will likely depend on this Swiss IDMP base FHIR IG. In turn, this base IG may build upon ch-core. Presumably, all of these artefacts will be aligned with the newer R6 version.
Globals Table
There are no Global profiles defined